A higher dose of vancomycin in continuous infusion is needed in critically ill patients

International Journal of Antimicrobial Agents

Volumn 37, Issue 1, 2011, Pages 75-77

  Jeurissen, A ^a   Sluyts, I ^a   Rutsaert, R ^a  

^a Sint Vincentiusziekenhuis   (Belgium)

Author keywords

Continuous infusion; Critically ill patients; Vancomycin

Indexed keywords

CREATININE; VANCOMYCIN;

CLINICAL ARTICLE; CONFERENCE PAPER; CONTINUOUS INFUSION; CONTROLLED STUDY; CREATININE CLEARANCE; CRITICAL ILLNESS; CRITICALLY ILL PATIENT; DOSE CALCULATION; DOSE KIDNEY FUNCTION RELATION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG HALF LIFE; DRUG MONITORING; GLOMERULUS FILTRATION; GRAM POSITIVE INFECTION; HUMAN; INFUSION RATE; INTENSIVE CARE UNIT; LOADING DRUG DOSE; NEPHROTOXICITY; NOMOGRAM; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STEADY STATE;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CRITICAL ILLNESS; HUMANS; INFUSIONS, INTRAVENOUS; PLASMA; VANCOMYCIN;

EID: 78650276949     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2010.09.004     Document Type: Conference Paper

References (15)

1. J.A. Roberts, J. Lipman, S. Blot, and J. Rello Better outcomes through continuous infusion of time-dependent antibiotics to critically ill patients? Curr Opin Crit Care 14 2008 390 396
2. J.D. Knudsen, K. Fuursted, S. Raber, F. Espersen, and Frimodt-Moller Pharmacodynamics of glycopeptides in the mouse peritonitis model of Streptococcus pneumoniae or Staphylococcus aureus infection Antimicrob Agents Chemother 44 2000 1247 1254
3. M. Wysocki, F. Delatour, F. Faurisson, A. Rauss, Y. Pean, and B. Misset Continuous versus intermittent infusion of vancomycin in severe staphylococcal infections: prospective multicenter randomized study Antimicrob Agents Chemother 45 2001 2460 2467
4. P.R. Ingram, D.C. Lye, D.A. Fisher, W.P. Goh, and V.H. Tam Nephrotoxicity of continuous versus intermittent infusion of vancomycin in outpatient parenteral antimicrobial therapy Int J Antimicrob Agents 34 2009 570 574
5. F. Pea, M. Furlanut, C. Negri, F. Pavan, M. Crapis, and F. Cristini Prospectively validated dosing nomograms for maximizing the pharmacodynamics of vancomycin administered by continuous infusion in critically ill patients Antimicrob Agents Chemother 53 2009 1863 1867
6. K.A. Rodvold, R.A. Blum, J.H. Fischer, H.Z. Zokufa, J.C. Rotschafer, and K.B. Crossley Vancomycin pharmacokinetics in patients with various degrees of renal function Antimicrob Agents Chemother 32 1988 848 852
7. E. Lowdin, I. Odenholt, and O. Cars In vitro studies of pharmacodynamic properties of vancomycin against Staphylococcus aureus and Staphylococcus epidermidis Antimicrob Agents Chemother 42 1998 2739 2744
8. M.J. Rybak The pharmacokinetic and pharmacodynamic properties of vancomycin Clin Infect Dis 42 Suppl. 1 2006 S35 S39
9. L.K. Hidayat, D.I. Hsu, R. Quist, K.A. Shriner, and A. Wong-Beringer High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity Arch Intern Med 166 2006 2138 2144
10. T.P. Lodise, B. Lomaestro, J. Graves, and G.L. Drusano Larger vancomycin doses (at least four grams per day) are associated with an increased incidence of nephrotoxicity Antimicrob Agents Chemother 52 2008 1330 1336
11. P.N. Panday, and M. Sturkenboom Continuous infusion of vancomycin less effective and safe than intermittent infusion, based on pharmacodynamic and pharmacokinetic principles Clin Infect Dis 49 2009 1964 1965 [author reply 1965]
12. G. Wang, J.F. Hindler, K.W. Ward, and D.A. Bruckner Increased vancomycin MICs for Staphylococcus aureus clinical isolates from a university hospital during a 5-year period J Clin Microbiol 44 2006 3883 3886
13. N. Revilla, A. Martín-Suárez, M.P. Pérez, F.M. Gonzáles, and M. Fernández de Gatta Mdel Vancomycin dosing assessment in intensive care unit patients based on a population pharmacokinetic/pharmacodynamic simulation Br J Clin Pharmacol 70 2010 201 212
14. P.R. Ingram, D.C. Lye, P.A. Tambyah, W.P. Goh, H.T. Vincent, and D.A. Fisher Risk factors for nephrotoxicity associated with continuous vancomycin infusion in outpatient parenteral antibiotic therapy J Antimicrob Chemother 62 2008 168 171
15. D. Hutschala, C. Kinstner, K. Skhirdladze, F. Thlhammer, M. Müller, and E. Tschernko Influence of vancomycin on renal function in critically ill patients after cardiac surgery Anesthesiology 111 2009 356 365